Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis

Completed

• Conditions: Osteoarthritis
• Interventions: Drug: Synvisc®

• Registration Number: NCT02195557
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

Retrospective collection of data, aimed at a better knowledge of the use of Synvisc® among the patients with knee osteoarthritis (OA) since at least three years.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-04
• Primary Completion: 2003-03
• Status Verified: 2014-07
• Study First Submitted: 2014-07-18
• Study First Submitted QC: 2014-07-18
• Study First Posted: 2014-07-21
• Last Update Submitted: 2014-07-21
• Last Update Posted: 2014-07-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Patients with knee osteoarthritis using Synvisc® since at least three years

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Synvisc®	Synvisc®	-

Primary Outcome Measures

Name	Time	Method
Number of other treatments per patient	at least 3 years of observation	antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs), specific symptomatic treatments and surgery
Time between two treatments	at least 3 years of observation
Reason for prescription	at least 3 years before start of observation period